Fluorescence Versus Intraoperative Cholangiography in the Visualization of Biliary Tree Anatomy
NCT ID: NCT01881399
Last Updated: 2018-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2013-11-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypothesis is that a fluorescence-based Imaging would allow visualization of the biliary tree anatomy as good as with the Intraoperative Cholangiogram with several main advantages:
1. ease of use
2. lack of invasiveness
3. absence of ionizing radiation to the patient and the operating staff
4. performed prior to any dissection (prior to "critical view of safety")
Capacity of enhanced-reality based on virtual cholangiography (computer treatment of MRI images) to guide biliary tree anatomy visualization will be also evaluated in this study.
The study requires a 2-month patient participation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Indocyanine Green Fluorescence During Fundus First Laparoscopic Cholecystectomy
NCT06918210
Cholecyst- Versus Cystic Duct Cholangiography During Laparoscopic Cholecystectomy
NCT01103570
The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy
NCT01424215
Gallbladder Infundibulum as a Guide for Ductal Identification.
NCT06239233
Virtual Reality Training for Laparoscopic Cholecystectomy
NCT05169073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluorescence/Virtual cholangiography/IOC
Prior to cholecystectomy, patients will undergo:
* Fluorescence cholangiography (visualization following up to a maximum of 0.5 mg/kg ICG - usually 10 ml of 0,5 mg/ml solution)
* Virtual cholangiography (enhanced-reality) superimposed on fluorescence images
* Conventional IOC (intraoperative cholangiography)
Fluorescence cholangiography (da Vinci surgical system)
Patients will received IV injection of ICG intra-operatively, allowing surgeons to view bile ducts under fluorescence imaging using the da Vinci surgical system with fluorescence Imaging system.
Virtual cholangiography
Images from virtual cholangiography will be superimposed in real time on images obtained with fluorescence.
Conventional IOC
Patients will undergo conventional intraoperative cholangiography (with use of radio-opaque dye), allowing surgeons to view bile ducts under Rx imaging.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluorescence cholangiography (da Vinci surgical system)
Patients will received IV injection of ICG intra-operatively, allowing surgeons to view bile ducts under fluorescence imaging using the da Vinci surgical system with fluorescence Imaging system.
Virtual cholangiography
Images from virtual cholangiography will be superimposed in real time on images obtained with fluorescence.
Conventional IOC
Patients will undergo conventional intraoperative cholangiography (with use of radio-opaque dye), allowing surgeons to view bile ducts under Rx imaging.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic gallbladder lithiasis or gallbladder polyps
* Clinical, biological ou medical imaging history leading to suspicion of gallstones migration
* Absence of contra-indication to anesthesia and cholecystectomy procedure
* Ability to understand the study related information and to provide written informed consent
* Registered with the French social security regime
* Inability to give informed consent
* Acute Cholecystitis
* Contraindications to MRI exam (claustrophobia, implantable devices)
* Potential risk of allergic reactions to iodine-containing contrast agents, to indocyanine green or other fluorescent compounds
* Pregnancy or breast-feeding
* Exclusion period from other clinical trial
* Forfeit freedom from an administrative or legal obligation
* Under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IHU Strasbourg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Pessaux, Pr
Role: PRINCIPAL_INVESTIGATOR
Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Diana M, Soler L, Agnus V, D'Urso A, Vix M, Dallemagne B, Faucher V, Roy C, Mutter D, Marescaux J, Pessaux P. Prospective Evaluation of Precision Multimodal Gallbladder Surgery Navigation: Virtual Reality, Near-infrared Fluorescence, and X-ray-based Intraoperative Cholangiography. Ann Surg. 2017 Nov;266(5):890-897. doi: 10.1097/SLA.0000000000002400.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A01664-39
Identifier Type: OTHER
Identifier Source: secondary_id
12-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.